Epigenetic targets for immune intervention in human malignancies. - Wikidata - wikimedia - TriplyDB

Epigenetic targets for immune intervention in human malignancies.

Epigenetic targets for immune intervention in human malignancies.

http://www.wikidata.org/entity/Q35551107

about

Generation of a genomic tiling array of the human major histocompatibility complex (MHC) and its application for DNA methylation analysis Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study The prognostic value of global DNA hypomethylation in cancer: a meta-analysis Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4 The silence of the genes: epigenetic disturbances in haematopoietic malignancies.Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance The biology of cancer testis antigens: putative function, regulation and therapeutic potential Decitabine: a promising epi-immunotherapeutic agent in solid tumors.Improving cancer immunotherapy with DNA methyltransferase inhibitors.Marked for death: targeting epigenetic changes in cancer.Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines.HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression.RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression.Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b.Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: immunotherapeutic implications.Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer.Epigenetic Mechanisms in Cancer Formation and Progression Epigenetically regulated tumor-associated antigens in melanoma

P2860

Q24288913-64D62F99-75C5-41D2-8759-3004D0D95161 Q24288944-6D00AEA2-D5A3-40E0-A93A-55BD19D44209 Q24540025-CF935C9A-504D-4FFA-939F-5BF5003CF6EA Q33715446-136E6D76-49C3-4D75-8C0C-19B4E518B9F9 Q33957165-2D37AF78-EAEC-4BD8-9EDD-7F9603046CF1 Q34502475-654979BF-17B9-4CC6-BAC9-53EB132406E3 Q34839826-0C6BC418-1DCE-46C4-98D8-EBB51CDF38C3 Q35237505-E8FEF8F6-C11F-456F-A75E-C350A47BEC4E Q35556061-F24678A6-4A79-42FB-ADC8-36BAFF88F3F4 Q36066276-3BC3A5A8-61DD-44E3-9100-9311F4ACBF37 Q36801625-C54E610A-5F55-43D6-A4C9-DB838EDD97DC Q37287152-721B0D09-57AF-4F1D-AACF-21DB317770CA Q37849976-4C336113-02E3-4600-ACEA-DDBB04781152 Q38314204-AB12AF97-2926-48EB-8A8B-B70C5A2F710F Q38662760-4998F975-4574-426E-8D4A-1C5A70B82DD4 Q38747872-5301BBD3-CCAF-4F91-BD82-63C200368428 Q38981497-AFB4CC8D-35AF-4B2A-BE92-825B5F8AC781 Q39211999-5DCEA5D0-E33A-4B26-A4A8-4CA6568FD4EF Q39544703-D345BA45-C42C-47CC-AA68-FF7CB72FF7B2 Q39586718-1221F1FF-8350-411F-BC5B-3744CF71E726 Q39916396-7F5D9F66-5C43-48DA-85B8-83FBEE055909 Q40277144-382837CC-04C9-4AE9-9E9B-ED6DFF33FCE0 Q40511605-61C52D47-D951-42CA-B194-253E190735C9 Q41550137-AC59AAC5-9EBF-4852-8A6F-E82BFAF837EB Q46017171-06CEF4CB-E127-486A-8D71-C023B5E38D8B Q57570317-A2481C00-FC26-42E8-A4F6-FAF834981AB3 Q57570339-EBD2715A-0187-4213-BC6A-88F425CE498C

P2860

Epigenetic targets for immune intervention in human malignancies.

http://www.wikidata.org/entity/Q35551107

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Epigenetic targets for immune intervention in human malignancies.

@ast

Epigenetic targets for immune intervention in human malignancies.

@en

type

label

Epigenetic targets for immune intervention in human malignancies.

@ast

Epigenetic targets for immune intervention in human malignancies.

@en

prefLabel

Epigenetic targets for immune intervention in human malignancies.

@ast

Epigenetic targets for immune intervention in human malignancies.

@en

P1433

Q35551107-9D3424E1-E9FB-415A-957D-931FFE7A5EE2

P1476

Q35551107-9C837ABF-56C0-43EE-9ABE-7015CA05D303

P2093

Q35551107-07C7E31E-7BC2-44B9-A123-23B44F1461BB

Q35551107-1C7126BA-ABB5-43EA-88D4-8AC2A2A66AAE

Q35551107-3E2E5F6A-30B4-42A5-8EDC-4A3CB406C3BA

Q35551107-E9039F89-D08E-4098-A3D6-9E6FCE61C7E1

Q35551107-F58B1778-9F59-4708-A69A-B4D44B8C4C26

P2860

Q35551107-08E9EF8E-31C4-4DF6-93D0-5678ADE78275

Q35551107-29193FF5-CFCE-4F6D-8D00-376773AC3C89

Q35551107-3A6F6FF9-1FFC-45D4-8633-ED8A75F41D65

Q35551107-3FD5C3D0-E918-4C74-8AA0-E31D3D19E192

Q35551107-4ADEFB1C-35EC-47BE-8BDB-104E211419FA

Q35551107-4D576047-5156-43A2-A10D-5E0CBAC8BDD1

Q35551107-5389F507-4FEB-4404-8E60-4107EDCD2E2A

Q35551107-68113AA8-0EF0-43A5-AA5C-84A58B59121E

Q35551107-98BC2582-A17E-4618-9514-EBBEA0FE703A

Q35551107-A6DF9C87-CC99-4CB0-9B1D-BA74B7ADD4F0

P2888

Q35551107-99EEC4E3-346E-4CF2-8C78-FA06BACDDD03

P304

Q35551107-AAD67B4D-5B91-4A04-8EE6-57519DDF1CC7

P31

Q35551107-340E28A2-3F0E-4FEA-8060-A1AAC880B0BE

P356

Q35551107-C5387E50-050B-4536-B17A-CB8F5B178496

P407

Q35551107-AF4476AF-389B-40F7-BF4B-581431110620

P433

Q35551107-C9F7BB73-5FCD-41B9-A655-F2E8F127B0AA

P478

Q35551107-1D6A1D35-6326-4FCF-B05B-045795A4B5B8

P577

Q35551107-53456DBF-B553-4F4A-9191-D9980429420B

P5875

Q35551107-7811B9EF-0893-427F-A1D1-CE09F98C65BF

P6179

Q35551107-D4647D03-822C-40ED-BC30-EE5D36A140BC

P698

Q35551107-D8F35974-F75B-4775-BFC8-54A6FB5532F0

P356

P1433

P1476

Epigenetic targets for immune intervention in human malignancies.

@en

P2093

Elisabetta Fratta

http://www.w3.org/2001/XMLSchema#string

Luca Sigalotti

http://www.w3.org/2001/XMLSchema#string

Maresa Altomonte

http://www.w3.org/2001/XMLSchema#string

Michele Maio

http://www.w3.org/2001/XMLSchema#string

Sandra Coral

http://www.w3.org/2001/XMLSchema#string

P2860

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas

Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.

Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo.

DNA methylation and cancer.

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients.

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy.

Cancer/testis-associated genes: identification, expression profile, and putative function.

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

P2888

P304

6484-6488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206956

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9064490

http://www.w3.org/2001/XMLSchema#string

P6179

1036901047

http://www.w3.org/2001/XMLSchema#string

P698

14528272

http://www.w3.org/2001/XMLSchema#string